1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Netherlands Pharmaceuticals and Healthcare Report Q4 2016

Netherlands Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 94 pages

Includes 3 FREE quarterly updates

BMI View:

We expect the Netherlands' pharmaceutical sector to return to growth in 2017, following an annual contraction of the market value since 2012. An ageing population and high per capita spending will drive medicine sales, ensuring the demand for prescription medicines remains high. However, despite an improvement in economic conditions, the rising cost of healthcare will put considerable pressure on the government to implement further cost- efficiencies.


Headline Expenditure Projections

- Pharmaceuticals: EUR5.95bn (USD6.63bn) in 2015 to EUR5.97bn (USD6.39bn) in 2016; -0.1% in local currency terms and -3.6% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: EUR72.78bn (USD80.72bn) in 2015 to EUR73.72bn (USD78.89bn) in 2016; +1.3% in local currency terms and -2.3% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Netherlands Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Netherlands 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Netherlands 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Netherlands 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Netherlands 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Netherlands 2012-2020) 24
OTC Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Netherlands 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Netherlands 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Netherlands 2014-2020) 29
Industry Risk Reward Index 30
Western Europe Risk/Reward Index 30
Netherlands Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Intellectual Property Issues 41
Pricing Regime 42
Reimbursement Regime 43
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Netherlands 2010-2015) 48
Table: Healthcare Personnel (Netherlands 2010-2015) 48
Table: Healthcare Activity (Netherlands 2010-2015) 49
Table: Key Points Of The Dutch Health Insurance Act, January 1 2006 51
Table: Biosimilars Approved In The EU 54
Research and Development 55
Netherlands Pharmaceuticals and Healthcare Report Q4 2016$$
Clinical Trials 56
Epidemiology 57
Competitive Landscape 60
Research-Based Industry 60
Table: Pharmaceutical Production, 1995-2010 (EUR '000s) 60
Generic Drugmakers 61
Table: Multinational Market Activity 62
Pharmaceutical Distribution 62
Pharmaceutical Retail Sector 63
Company Profile 66
DSM 66
GlaxoSmithKline 69
Merck and Co 71
Novartis 73
Pfizer 75
Pharming Group 77
Qiagen 79
Sanofi 81
Demographic Forecast 83
Demographic Outlook 83
Table: Population Headline Indicators (Netherlands 1990-2025) 84
Table: Key Population Ratios (Netherlands 1990-2025) 84
Table: Urban/Rural Population and Life Expectancy (Netherlands 1990-2025) 85
Table: Population By Age Group (Netherlands 1990-2025) 85
Table: Population By Age Group % (Netherlands 1990-2025) 86
Glossary 88
Methodology 90
Pharmaceutical Expenditure Forecast Model 90
Healthcare Expenditure Forecast Model 90
Notes On Methodology 91
Risk/Reward Index Methodology 92
Index Overview 93
Table: Pharmaceutical Risk/Reward Index Indicators 93
Indicator Weightings 94

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.